Patient-Specific Decisions About Hormone Replacement Therapy in Postmenopausal Women
- 9 April 1997
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 277 (14), 1140-1147
- https://doi.org/10.1001/jama.1997.03540380054031
Abstract
Objective. —To examine the effect of hormone replacement therapy on life expectancy in postmenopausal women with different risk profiles for heart disease, breast cancer, and hip fracture. Design. —Decision analysis using a Markov model. Published regression models were used to link risk factors to disease incidence and to estimate the lifetime risks of developing coronary heart disease (CHD), breast cancer, hip fracture, and endometrial cancer. The impact of hormone therapy on disease incidence was estimated from published epidemiologic studies. Setting. —Mathematical model applicable to primary care. Interventions. —Treatment with hormone replacement therapy or no hormone replacement therapy. Main Outcome Measure. —Life expectancy. Results. —Hormone replacement therapy should increase life expectancy for nearly all postmenopausal women, with some gains exceeding 3 years, depending mainly on an individual's risk factors for CHD and breast cancer. For women with at least 1 risk factor for CHD, hormone therapy should extend life expectancy, even for women having first-degree relatives with breast cancer. Women without any risk factors for CHD or hip fracture, but who have 2 first-degree relatives with breast cancer, however, should not receive hormone therapy. Conclusions. —The benefit of hormone replacement therapy in reducing the likelihood of developing CHD appears to outweigh the risk of breast cancer for nearly all women in whom this treatment might be considered. Our analysis supports the broader use of hormone replacement therapy.Keywords
This publication has 61 references indexed in Scilit:
- Attitudes of women toward hormone therapy and prevention of heart diseaseAmerican Heart Journal, 1995
- Perceptions of Breast Cancer Risk and Screening Effectiveness in Women Younger Than 50 Years of AgeJNCI Journal of the National Cancer Institute, 1995
- Hip fractures in the elderly: A world-wide projectionOsteoporosis International, 1992
- Cardiovascular disease risk profilesAmerican Heart Journal, 1991
- Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidencePreventive Medicine, 1991
- Menopause and the Risk of Coronary Heart Disease in WomenThe New England Journal of Medicine, 1987
- A Prospective Study of Postmenopausal Estrogen Therapy and Coronary Heart DiseaseThe New England Journal of Medicine, 1985
- Fractures of the hip in the elderly: therapeutic and medico-social considerationsArchives of Gerontology and Geriatrics, 1984
- The Toss-upThe New England Journal of Medicine, 1981
- Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of EstrogenThe New England Journal of Medicine, 1980